Periodic Reporting for period 1 - T-FRAME (Real-time analysis of ribosomal frameshifting and its impact on immunity and disease)
Reporting period: 2021-02-01 to 2022-07-31
- Identifying putative host cellular and viral factors that modulate translation of frameshift RNAs.
- Defining structural features of cis- and trans-acting frameshift regulators, and elucidating how they impede translation elongation.
- characterizing how frameshift regulators impact infections and immune response.
A comprehensive analysis of frameshift regulation will allow controlling and precisely targeting these RNA molecules, which I hope will eventually provide new design principles for RNA-centric antiviral and immune therapies.
The main objectives of the T-FRAME project are:
Understanding the mechanism of protein-mediated frameshifting in eukaryotes
Discovery of novel host and viral factors that regulate translation of frameshifting genes
Defining the scope and dynamics of frameshifting in immune cells upon infection or activation by interferons.
Our next aim was to mechanistically characterize the interactions of cardiovurus 2A and EMCV RNA in more detail. Interactions between RNA and interacting partners are usually short-lived, or weak making it difficult to decipher the underlying physical principles and precise control mechanisms. In order to gain an in-depth insight into RNA dynamics, we employ state of the art optical tweezers with high-resolution imaging and microfluidics. The combination of these techniques allows us to obtain spatial and dynamic information on RNA structures, which lead to translation pauses and the movement of ribosomes into the –1 reading frame.
In the upcoming period, we will further develop our assays to directly visualize how cis and trans-acting elements interact with the translation apparatus in real-time.
.